Risk profiles for mild cognitive impairment vary by age and sex: the Sydney Memory and Ageing study
- PMID: 22673190
- DOI: 10.1097/JGP.0b013e31825461b0
Risk profiles for mild cognitive impairment vary by age and sex: the Sydney Memory and Ageing study
Abstract
Objectives: : To examine age- and sex-related differences in risk and protective factors for mild cognitive impairment (MCI) in community-based elderly individuals.
Design: : Cross-sectional study.
Setting: : The population-based Sydney Memory and Ageing Study.
Participants: : A total of 757 nondemented, community-dwelling elderly individuals from an English-speaking background categorized as younger (70-79 years) or older (80-90 years).
Measurements: : Risk of MCI was determined for sociodemographic, lifestyle, and cardiac, physical, mental, and general health factors using age- (and sex-) adjusted multiple regressions comprising initially significant univariate factors.
Results: : The point prevalence of MCI within our sample was 39.1% overall: it was lowest in younger women (32.3%) and similar across men and older women (41.9%-43.6%). The risk of MCI across all participants was increased by the APOE ∊4 allele, high homocysteine, and heart disease; and decreased by better odor identification, visual acuity, and mental activity. Risk factors in all younger participants were slow 6-m walk, poor odor identification, and high homocysteine. Risk of MCI was associated in younger women with history of depression, less mental activity, slower 6-m walk, poorer visual acuity, and higher homocysteine; and in younger men with poorer odor identification and higher homocysteine. Older participants showed no significant risk factors for MCI, except for poorer visual acuity in men. Supporting these findings were statistically significant interactions that reflected the differences in risk factor profiles between age and/or sex groups.
Conclusions: : Risk factors for MCI differ in men and women and vary with age. This has implications for preventing MCI and possibly dementia.
Similar articles
-
Risk profiles of subtypes of mild cognitive impairment: the sydney memory and ageing study.J Am Geriatr Soc. 2012 Jan;60(1):24-33. doi: 10.1111/j.1532-5415.2011.03774.x. Epub 2011 Dec 5. J Am Geriatr Soc. 2012. PMID: 22142389
-
Can mild cognitive impairment be accurately diagnosed in english speakers from linguistic minorities? Results from the Sydney Memory and Ageing study.Am J Geriatr Psychiatry. 2012 Oct;20(10):866-77. doi: 10.1097/JGP.0b013e31823e31e2. Am J Geriatr Psychiatry. 2012. PMID: 22261551
-
Sydney Memory and Ageing Study: an epidemiological cohort study of brain ageing and dementia.Int Rev Psychiatry. 2013 Dec;25(6):711-25. doi: 10.3109/09540261.2013.860890. Int Rev Psychiatry. 2013. PMID: 24423224 Clinical Trial.
-
Prevalence of minor depression in elderly persons with and without mild cognitive impairment: a systematic review.J Affect Disord. 2014 Jan;152-154:28-38. doi: 10.1016/j.jad.2013.09.016. Epub 2013 Sep 25. J Affect Disord. 2014. PMID: 24103852 Review.
-
Mild cognitive impairment: disparity of incidence and prevalence estimates.Alzheimers Dement. 2012 Jan;8(1):14-21. doi: 10.1016/j.jalz.2011.01.002. Alzheimers Dement. 2012. PMID: 22265588 Review.
Cited by
-
Risk factors for cognitive impairment in middle-aged type 2 diabetic patients: a cross-sectional study.BMJ Open. 2024 Jan 2;14(1):e074753. doi: 10.1136/bmjopen-2023-074753. BMJ Open. 2024. PMID: 38167287 Free PMC article.
-
Cognitive complaints in older adults in primary care and associated factors.Dement Neuropsychol. 2023 May 29;17:e20220096. doi: 10.1590/1980-5764-DN-2022-0096. eCollection 2023. Dement Neuropsychol. 2023. PMID: 37261254 Free PMC article.
-
Alcohol Consumption and Mild Cognitive Impairment: A Mendelian Randomization Study from Rural China.Nutrients. 2022 Aug 31;14(17):3596. doi: 10.3390/nu14173596. Nutrients. 2022. PMID: 36079852 Free PMC article.
-
Microbial Therapeutics in Neurocognitive and Psychiatric Disorders.J Clin Med Res. 2021 Sep;13(9):439-459. doi: 10.14740/jocmr4575. Epub 2021 Sep 30. J Clin Med Res. 2021. PMID: 34691318 Free PMC article. Review.
-
Role of MT1A Polymorphism and Environmental Mercury Exposure on the Montreal Cognitive Assessment (MoCA).Neuropsychiatr Dis Treat. 2021 Jul 22;17:2429-2439. doi: 10.2147/NDT.S320374. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 34326641 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
